Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy. (2017)
Attributed to:
Chemical bioreductive approaches to targeted radiosensitisation and imaging of tumours
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ijrobp.2017.03.024
PubMed Identifier: 28721903
Publication URI: http://europepmc.org/abstract/MED/28721903
Type: Journal Article/Review
Volume: 98
Parent Publication: International journal of radiation oncology, biology, physics
Issue: 5
ISSN: 0360-3016